Today: 9 June 2026
Browse Category

NYSE:KGC 26 September 2025 - 18 March 2026

B2Gold Corp. Stock Falls Nearly 5% as Gold Slips Below $5,000 and Goose Risks Return

B2Gold Corp. Stock Falls Nearly 5% as Gold Slips Below $5,000 and Goose Risks Return

B2Gold shares fell nearly 5% Wednesday as gold dropped below $5,000 an ounce after the Federal Reserve held rates steady and warned on inflation. The miner’s 2026 cost outlook is based on gold at $5,000, but spot gold slid 2.9% to $4,860.21. B2Gold expects lower 2026 output, with most Goose mine production coming later in the year. Founder Clive Johnson will step down as CEO on June 4.
Newmont stock price: why NEM rose as gold tops $5,100 and Scotiabank lifts target to $152

Newmont stock price: why NEM rose as gold tops $5,100 and Scotiabank lifts target to $152

Newmont shares rose 1.3% to $125.92 in after-hours trading Monday as gold prices hit a record $5,100 an ounce. Trading volume reached about 13.1 million shares. Scotiabank raised its price target for Newmont to $152, citing economic uncertainty and higher gold forecasts. The company’s Boddington mine in Australia resumed operations at reduced capacity after bushfires, with a Q1 production shortfall expected.
B2Gold stock rises again as gold tops $4,800 — what investors are watching next

B2Gold stock rises again as gold tops $4,800 — what investors are watching next

B2Gold shares rose about 2% to $5.01 Wednesday as spot gold surged past $4,800 an ounce for the first time, fueled by safe-haven demand amid tensions over Greenland. Traders cited geopolitics and a weaker dollar as key drivers. Gold miners’ stocks tracked bullion higher in early U.S. trading. Markets await President Trump’s Davos speech for further cues.
Gold price smashes $4,600 record and gold stocks jump — here’s what traders watch next

Gold price smashes $4,600 record and gold stocks jump — here’s what traders watch next

Newmont jumped nearly 4% Monday as gold hit a record above $4,600 an ounce amid political unrest and a standoff over Fed Chair Jerome Powell. The dollar index fell 0.4% to 98.84 after Powell disclosed subpoenas tied to his testimony. Gold futures rose 2.1% to $4,596.70, while the SPDR Gold Shares ETF gained 2.4%. Investors are watching U.S. CPI data and the Fed meeting on Jan. 27-28.
Gold price today rebounds after Monday plunge; Newmont stock, GLD ETF rise

Gold price today rebounds after Monday plunge; Newmont stock, GLD ETF rise

Spot gold rebounded to $4,380 an ounce Tuesday morning after Monday’s sharp selloff, up about 0.9% on the day, JM Bullion data showed. Newmont rose 0.6% and SPDR Gold Shares gained 0.5%. Investors are awaiting the Federal Reserve’s December meeting minutes for signals on 2026 rate cuts. China’s net gold imports via Hong Kong more than doubled in November to 16.16 metric tons.
Kinross Gold stock slides 5% as metals retreat from record highs; Fed minutes ahead

Kinross Gold stock slides 5% as metals retreat from record highs; Fed minutes ahead

Kinross Gold shares dropped 5% to $28.21 Monday as gold and silver prices plunged from record highs, with spot gold down 4.5% and silver off 9.5%. The Chicago Mercantile Exchange raised margin requirements for gold and silver futures late Friday. Newmont shares fell 5.6%. Investors await Federal Reserve minutes Tuesday for signals on rates and market direction.
Precious Metals Boom: Gold Nears Record High, Silver Hits 14-Year Peak as Fed Pivot and Tariff Shocks Spark Rally

Precious Metals Boom: Gold Nears Record High, Silver Hits 14-Year Peak as Fed Pivot and Tariff Shocks Spark Rally

Gold hovered near $3,750/oz Friday after hitting a record $3,790 earlier in the week, up over 40% in 2025. Silver surged above $45/oz for the first time since 2011, gaining 55% year-to-date. U.S. tariffs announced by President Trump fueled safe-haven flows. Platinum and palladium also climbed, while gold ETF inflows hit records in September.

Stock Market Today

  • Eli Lilly Shares Rise Premarket on Successful Late-Stage Weight Loss Trial
    June 8, 2026, 7:25 PM EDT. Eli Lilly's shares rose in premarket trading following positive results from a late-stage trial of retatrutide, a drug designed for weight loss. The trial demonstrated the drug's effectiveness not only in reducing weight but also in alleviating conditions linked to obesity, highlighting potential new treatment options in the growing obesity market.

Latest articles

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Peso Rebounds, But Mexico’s Next Inflation Print Looms

Peso Rebounds, But Mexico’s Next Inflation Print Looms

9 June 2026
Mexico’s peso edged up 0.09% to 17.4644 per dollar after Iran and Israel paused attacks, but traders turned cautious ahead of Tuesday’s Mexico inflation data, which could shape Banxico rate expectations and impact the peso’s yield advantage that has supported the currency.
T1 Energy Shares Dip After KORE Power Files New Update

T1 Energy Shares Dip After KORE Power Files New Update

9 June 2026
T1 Energy shares slid 3.2% to $9.13 after a new SEC filing revealed up to $24.7 million in stock-linked payments for its $32 million KORE Power acquisition, spotlighting dilution risks as the company expands into battery storage and data-center power; the deal’s structure and timing come as T1 seeks growth funding and investors weigh near-term costs against future EBITDA targets.
Go toTop